Cormedix Inc

This advisory Say-on-Pay proposal asks holders to endorse the Company’s 2025 executive compensation program; while non‑binding, the Board and Compensation Committee view the outcome as important feedback and will consider the results. Management states compensation is performance‑based and structured to align pay with long‑term shareholder value and competitive market practice, including base salary, annual bonus targets, restricted stock units and performance stock units. The Board recommends FOR because it believes the mix of short‑ and long‑term incentives, performance metrics, and vesting schedules appropriately align executives’ interests with shareholders and support retention following the Melinta acquisition and commercialization efforts. Critics might point to the magnitude of equity awards granted in 2025 (notably large RSU and performance PSU grants disclosed) and question whether realized pay is sufficiently performance‑contingent, especially in a year of transformational M&A activity. The Company responds by emphasizing multi‑year performance vesting and relative TSR‑based PSUs, which tie ultimate payout to shareholder returns over the performance period. In evaluating the proposal, an analyst should weigh the strength of explicit performance conditions, potential single‑year increases in grant values tied to corporate events (e.g., acquisition integration), and the company’s compensation governance (use of an independent compensation consultant and Compensation Committee oversight). Given the advisory nature, a negative vote would not change pay immediately but would likely trigger engagement and potential plan revisions. The Board’s rationale centers on retention, alignment with peers, and incentivizing delivery on commercial and integration objectives in 2026 and beyond. Overall, the proposal is a governance feedback mechanism rather than an operational mandate, and investors should judge both program design and the Board’s responsiveness to stockholder concerns.

This proposal seeks retrospective stockholder ratification under Section 204 of the DGCL of a series of historical amendments to the Company’s certificates of designation for Series E and Series C‑3 preferred stock. The Board initiated the ratification after a stockholder questioned whether required approvals or class votes were obtained for certain amendments; management and counsel concluded the amendments were properly authorized but are seeking stockholder ratification to eliminate any lingering legal uncertainty. Ratification, if approved, would allow certificates of validation to be filed and render the amendments effective retroactively to their original filing dates, limiting the window for legal challenges and reducing the risk of disruptive litigation. The voting mechanics are complex: approval requires multiple class and series thresholds including separate supermajority votes of preferred series and a majority of common stock in certain combinations, and abstentions and broker non‑votes will count as negative votes for this proposal. From a governance perspective, the step is defensive—reducing regulatory and transactional risk by converting a possible procedural defect into a validated corporate act—but it also has the practical effect of affirming prior governance choices that changed preferred‑holder rights (including removal of certain consent requirements). Investors should evaluate the proposal in light of the underlying amendments’ economic effects (e.g., conversion ratios, dividend provisions, anti‑dilution adjustments) and the identities of preferred holders (notably affiliates of Elliott Associates hold Series E) that may have materially different voting power. A vote against could leave unresolved legal exposure and potentially invite costly Chancery proceedings; a vote for prioritizes legal certainty and avoids management distraction, but also forecloses challenges that might otherwise negotiate different outcomes for common holders. The Board’s unanimous recommendation and the filing of Appendix B (board resolutions) signal management’s intent to finalize validation promptly if approved. In sum, the proposal is primarily legal‑structural insurance rather than a substantive change to ongoing governance, but it materially affects capital‑structure certainty and the enforceability of prior amendments.

This management proposal requests shareholder approval of an Amended Charter containing predominantly immaterial and technical updates: updating the registered agent address, removing references to preferred‑series that are no longer outstanding, eliminating references to the 2019 reverse stock split, revising indemnification language to align with the By‑Laws, and adding article titles for clarity. Management frames this as housekeeping that consolidates and modernizes the governing document so stockholders have a single clear instrument rather than multiple historical amendments and obsolete provisions. The proposed amendments are not presented as substantively altering stockholder rights or economic terms, and the Board emphasizes consistency with peer documents and improved clarity for investors and counterparties. The vote requires class votes including supermajority thresholds for certain preferred series, so the approval mechanics reflect the Charter’s existing protective provisions for preferred holders. Analysts should confirm that the Appendix C redline contains only the described technical edits and that no hidden provisions change substantive governance or transfer rights between classes. Potential shareholder concerns are limited but could focus on ensuring that removal of obsolete references does not unintentionally alter interpretation of past amendments; management’s explanation and the availability of the full Amended Charter in Appendix C should mitigate these concerns. If approved, the Company will file a single restated certificate that should reduce administrative friction and legal ambiguity in future transactions. The Board’s unanimous recommendation indicates confidence that these are non‑controversial modernization steps that enhance corporate housekeeping without diminishing shareholder protections.

This proposal seeks to add a new paragraph to Article Fourth of the Charter that clarifies class‑voting procedures: where an amendment solely affects one or more series of preferred stock, only the holders of the affected series (or combined affected series) need vote on that amendment rather than requiring a separate common stockholder vote. Management frames the amendment as a clarification that aligns voting requirements with the interests directly affected and avoids the logistical and financial costs of broad shareholder solicitations for changes that do not affect common stock rights. The Board previously proposed this change at the 2025 Special Meeting and obtained substantial support from voting stockholders but fell short of the required vote; resubmitting the proposal reflects management’s view that the change is both lawful and widely supported. For investors, the key issue is whether this reduces meaningful oversight by common holders over preferred‑class changes that could indirectly affect common economics; management emphasizes that the proposal does not permit changes to common‑stock terms without common holder approval and is expressly subject to applicable law. Opponents could argue the amendment might facilitate preferred‑holder actions that, while formally limited to preferred terms, could shift economic outcomes or governance dynamics; such concerns should be evaluated against the specific rights reserved to common holders and the identity and voting power of preferred holders. The required voting thresholds include combined class and series supermajorities, reflecting protections for both common and preferred constituents. If adopted, the change should reduce transaction costs and speed the administration of preferred‑series amendments, but analysts should monitor the composition of preferred holders and potential future amendments that could be affected by this procedural change. Overall, the Board’s recommendation and prior stockholder support suggest this is primarily a technical alignment with Delaware class‑voting principles rather than a reallocation of substantive rights.

This proposal would add a new Article Ninth to the Charter selecting exclusive forums for a range of corporate disputes: the Delaware Court of Chancery (or federal district court for District of Delaware if Chancery lacks jurisdiction) for derivative claims, fiduciary‑duty claims, internal affairs matters, and related disputes; and the federal district courts of the United States for claims arising under the Securities Act. Management argues the measure reduces the risk of parallel litigation in multiple jurisdictions, leverages Delaware courts’ expertise in corporate law matters, and lowers legal costs and the chance of inconsistent outcomes. Opponents often contend exclusive‑forum provisions can disadvantage plaintiffs by imposing venue constraints and may impede appellate strategy or access to jury trial rights for certain securities claims; the Company’s carve‑out of federal courts for Securities Act claims is designed to address one such concern. Legal enforceability has generally been upheld in Delaware and elsewhere, but courts may scrutinize forum‑selection clauses for fairness and notice; the Company makes consent explicit by deeming stockholders to have notice and consent upon acquiring shares. From a risk perspective, adopting the provision should materially reduce litigation complexity, but investors should consider how it interacts with class action strategy, potential forum shopping, and the Company’s litigation history. The Board recommends FOR on efficiency and predictability grounds; however, governance activists sometimes oppose blanket forum restrictions as limiting stockholder rights. Overall, the amendment is a common governance tool among Delaware corporations aimed at consolidating complex internal corporate litigation in a specialized forum.

This proposal would amend Article Fifth to extend to officers a limitation on personal monetary liability for duty‑of‑care breaches to the maximum extent permitted by Section 102(b)(7) of the DGCL, while preserving liability for breaches of duty of loyalty, acts not in good faith, intentional misconduct, knowing violations of law, transactions where an officer derived improper personal benefit, and claims brought by or in the right of the Company. Management frames the change as a targeted recruitment and retention tool, arguing qualified officer candidates may otherwise be deterred by exposure to duty‑of‑care claims that can impose defense costs irrespective of merit. The amendment is positioned as aligning officer protections with existing director exculpation and with practices adopted by many peers following the DGCL amendment enabling officer exculpation. From a governance standpoint, the change reduces the risk of nuisance suits and related insurance and defense costs, but critics could argue it narrows remedies available to shareholders for certain negligent‑type officer conduct. The Company highlights that the change does not affect derivative or company‑brought claims and excludes serious misconduct from protection, preserving core accountability. Analysts should assess the balance between lowering litigation risk and maintaining effective deterrents against negligent oversight, and consider the Company’s insurance and indemnification arrangements. Because the amendment would be part of the Charter, it requires a shareholder vote and will be effective upon filing if approved; the Board’s unanimous recommendation underscores the management view that the benefits to officer recruitment and reduced litigation risk outweigh potential investor concerns.

This procedural proposal asks shareholders to empower the Board to adjourn the Annual Meeting to allow further solicitation if Proposals 4 through 8 do not receive sufficient votes at the scheduled meeting. Management argues that the adjournment authority protects stockholder interests by facilitating additional outreach and allowing a fuller and more informed vote, rather than permitting important charter or validation measures to fail on purely logistical grounds or because of incomplete proxy returns. For analysis, the adjournment authority is neutral from a governance-change perspective— it does not change substantive rights, but it enables management to continue solicitation efforts which can be used legitimately to secure required supermajorities for charter amendments. Opponents may worry that adjournment can be used tactically to wear down opposition or delay an adverse outcome, but the proposal is narrowly tailored to a specific set of proposals (COD ratification and charter amendments) and operates under standard quorum and voting rules. The vote is advisory but required to grant the Board the practical flexibility to achieve the necessary votes within Delaware’s validation timelines (notably the 120‑day challenge window under Section 204/205). Investors should view this as a contingency mechanism to ensure that technically complex, class‑vote dependent proposals have an opportunity for full consideration rather than a device to override clear stockholder opposition. The Board’s unanimous recommendation indicates management’s preference to preserve options for completing the ratification and charter update process if initial vote tallies are insufficient.